BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Daiichi Sankyo, AstraZeneca’s Enhertu Wins EU Panel Backing for Early Breast Cancer

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% vers...

September 21, 2026 | News

2026 in 26 Numbers: The APAC Biopharma Year, Counted

METHOD IN BRIEF A number qualifies for this list only if it is sourced to a company disclosure, regulator publication, exchange filing or peer-...

September 21, 2026 | Analysis

Nona Biosciences Develops AI Language Model for Fully Human Heavy-Chain-Only Antibodies

Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, annou...

September 18, 2026 | News

Waters Launches BD FACSDiscover A7 Cell Analyzer to Expand Access to Advanced Flow Cytometry

Waters Corporation announced the global commercial launch of the BD FACSDiscover™ A7 Cell Analyzer, which uniquely combines exceptional spectra...

September 17, 2026 | News

Takeda’s Zasocitinib Receives US FDA Priority Review for Plaque Psoriasis

-Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) under Priority Review for za...

September 16, 2026 | News

AstraZeneca, Daiichi Sankyo’s ENHERTU Cuts Disease Progression Risk by 37% in HER2-Mutant Lung Cancer

AstraZeneca and Daiichi Sankyo’s ENHERTU is the first HER2-directed therapy to delay disease progression over standard of care in a Phase III trial...

September 16, 2026 | News

Single Cell Discoveries Acquires TATAA Biocenter to Build Integrated Discovery-to-Validation CRO

Single Cell Discoveries (SCD), a specialist contract research organization (CRO) focused on discovery transcriptomics, has completed the acquisition of TAT...

September 16, 2026 | News

Thermo Fisher Scientific Launches 250-Litre Heratherm Environmental Chambers for Stability Testing and Quality Control

Thermo Fisher Scientific has introduced the Thermo Scientific™ Heratherm™ Environmental Chambers with a 250-litre capacity, expanding its envir...

September 16, 2026 | News

Accro Bioscience’s AC-101 Enters China’s Rare Disease Innovative Drug Pilot Programme for Blau Syndrome

Accro Bioscience announced that AC-101 tablets have been included in the Rare Diseases Innovative Drug Development Encouragement Pilot Program (the "Caring...

September 15, 2026 | News

Evinova, Lothar Medical Partner to Digitise Respiratory Clinical Trials

Evinova, a global leader in AI-native clinical development technology, announced a strategic partnership with Lothar Medical to help transform the ex...

September 08, 2026 | News

EpiVax Adds AI-Enabled Enhancements to ISPRI Immunogenicity Risk Platform

EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the ...

September 04, 2026 | News

Genprex Selects Andelyn Biosciences to Scale Up AAV Gene Therapy for Diabetes

Andelyn Biosciences, a leading contract development and manufacturing organization, announced that Genprex, Inc. has selected Andelyn to support scale-up m...

September 03, 2026 | News

IDT and Ansa Expand Global Access to Complex DNA Synthesis Through Integrated Ordering

Streamlined workflow provides earlier visibility into synthesis feasibility, pricing, and fulfillment options Global adoption growing with more than 400...

September 03, 2026 | News

US FDA Grants Fast Track Designation to T-MAXIMUM’s Allogeneic CAR-T Therapy for Recurrent Glioblastoma

T-MAXIMUM PHARMACEUTICAL Inc. ("T-MAXIMUM") announced that its investigational allogeneic CAR-T cell therapy MT027 has been granted Fast Track Designation ...

September 02, 2026 | News

Stay Connected